BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 18402267)

  • 1. [Allergen-specific immunotherapy in allergic rhinitis].
    Klimek L; Grevers G
    MMW Fortschr Med; 2008 Feb; 150(9):29-33; quiz 34. PubMed ID: 18402267
    [No Abstract]   [Full Text] [Related]  

  • 2. Subcutaneous versus sublingual immunotherapy.
    Lin CH; Alandijani S; Lockey RF
    Expert Rev Clin Immunol; 2016 Aug; 12(8):801-3. PubMed ID: 27253418
    [No Abstract]   [Full Text] [Related]  

  • 3. [The value and possibilities of immunotherapy in the treatment of allergic rhinitis].
    Pfaar O; Hörmann K; Klimek L
    MMW Fortschr Med; 2006 Feb; 148(5):28-32. PubMed ID: 16518935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Allergen specific immunotherapy: new approaches].
    Tay F; Kündig TM; Senti G
    Praxis (Bern 1994); 2010 Oct; 99(21):1279-84. PubMed ID: 20960398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcutaneous allergen immunotherapy in 3 patients with HIV.
    Fodeman J; Jariwala S; Hudes G; Jerschow E; Rosenstreich D
    Ann Allergy Asthma Immunol; 2010 Oct; 105(4):320-1. PubMed ID: 20934633
    [No Abstract]   [Full Text] [Related]  

  • 6. Meta-analyses of specific immunotherapy trials.
    Calderon MA
    Drugs Today (Barc); 2008 Dec; 44 Suppl B():31-4. PubMed ID: 19221615
    [No Abstract]   [Full Text] [Related]  

  • 7. [Vaccination with allergens in children].
    Demoly P; Dhivert-Donnadieu H; Bousquet J
    Allerg Immunol (Paris); 2000 Dec; 32(10):397-401. PubMed ID: 11209473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Allergen-specific immunotherapy].
    Hansen TK; Svendsen UG
    Ugeskr Laeger; 2005 Feb; 167(6):666-71. PubMed ID: 15771384
    [No Abstract]   [Full Text] [Related]  

  • 9. Allergic rhinitis. Outcomes of immunotherapy on symptom control.
    Cook PR
    Otolaryngol Clin North Am; 1998 Feb; 31(1):129-40. PubMed ID: 9530682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term benefits of specific immunotherapy (SIT).
    Olaguibel JM
    Drugs Today (Barc); 2008 Dec; 44 Suppl B():39-41. PubMed ID: 19221617
    [No Abstract]   [Full Text] [Related]  

  • 11. [Allergen-specific immunotherapy (hyposensitization). Part 2. Oral, sublingual and nasal application].
    Fuchs T; Klimek L
    HNO; 2000 Feb; 48(2):158-64. PubMed ID: 10663067
    [No Abstract]   [Full Text] [Related]  

  • 12. Subcutaneous versus sublingual immunotherapy for allergic rhinitis and/or asthma.
    Bahceciler NN; Cobanoglu N
    Immunotherapy; 2011 Jun; 3(6):747-56. PubMed ID: 21668312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of sublingual immunotherapy.
    Scadding G; Durham S
    J Asthma; 2009 May; 46(4):322-34. PubMed ID: 19484663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Subcutaneous allergen-specific immunotherapy in patients with asthma and allergic rhinitis. 21st century].
    Martín JP
    Rev Alerg Mex; 2009; 56(2):27-9. PubMed ID: 19526950
    [No Abstract]   [Full Text] [Related]  

  • 15. Allergen-specific immunotherapy in allergic rhinitis and asthma. Mechanisms and proof of efficacy.
    Pipet A; Botturi K; Pinot D; Vervloet D; Magnan A
    Respir Med; 2009 Jun; 103(6):800-12. PubMed ID: 19216064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of asthma and allergies.
    Jacobsen L
    Drugs Today (Barc); 2008 Dec; 44 Suppl B():79-82. PubMed ID: 19221626
    [No Abstract]   [Full Text] [Related]  

  • 17. Short-term subcutaneous grass pollen immunotherapy under the umbrella of anti-IL-4: A randomized controlled trial.
    Chaker AM; Shamji MH; Dumitru FA; Calderon MA; Scadding GW; Makatsori M; Jones I; He QA; Subramanian KK; Arm JP; Durham SR; Schmidt-Weber CB
    J Allergy Clin Immunol; 2016 Feb; 137(2):452-461.e9. PubMed ID: 26531865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [What is reliable in hyposensitization of IgE-induced diseases? Indications, contraindications, results and side effects].
    Fuchs T
    Internist (Berl); 1991 Dec; 32(12):721-8. PubMed ID: 1783514
    [No Abstract]   [Full Text] [Related]  

  • 19. Multiallergen-specific immunotherapy in polysensitized patients: where are we?
    Bahceciler NN; Galip N; Cobanoglu N
    Immunotherapy; 2013 Feb; 5(2):183-90. PubMed ID: 23413909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The practical role of serum allergen-specific IgE as potential biomarker for predicting responder to allergen immunotherapy.
    Ciprandi G; Tosca MA; Silvestri M
    Expert Rev Clin Immunol; 2014 Mar; 10(3):321-4. PubMed ID: 24450987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.